Pelthos Therapeutics Inc.
PTHS
$23.42
-$1.13-4.60%
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 43.07% | 16.16% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 43.07% | 16.16% | |||
| Cost of Revenue | 126.47% | -9.14% | |||
| Gross Profit | 25.93% | 23.21% | |||
| SG&A Expenses | 24.02% | 14.27% | |||
| Depreciation & Amortization | 1.16% | 17.56% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 30.97% | 12.16% | |||
| Operating Income | -20.90% | -9.04% | |||
| Income Before Tax | 6.60% | 12.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.60% | -15.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.60% | -15.74% | |||
| EBIT | -20.90% | -9.04% | |||
| EBITDA | -25.15% | -7.44% | |||
| EPS Basic | 12.58% | -10.20% | |||
| Normalized Basic EPS | 18.18% | 15.64% | |||
| EPS Diluted | 12.58% | -10.20% | |||
| Normalized Diluted EPS | 18.18% | 15.64% | |||
| Average Basic Shares Outstanding | 6.84% | 5.02% | |||
| Average Diluted Shares Outstanding | 6.84% | 5.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||